Cannabis
Legal Sale of Cannabis in Germany: Pilot Projects in Frankfurt and Hanover
Germany’s evolving cannabis policy now allows adults to possess up to 25 grams and grow three plants. Pilot projects in Hanover and Frankfurt will permit regulated sales to assess the social, health, and economic impacts of legal cannabis. These initiatives aim to combat black market issues and offer insights for shaping future drug policy globally.
In 2024, Germany took its drug policy reform to the next level by launching pilot projects that allow the legal sale of cannabis for adult use. In Frankfurt and Hanover, pioneering initiatives have been launched that could become models for future national cannabis regulation.
Germany’s drug policy is undergoing a transformation. Since April 2024, after months of political debate, adults in Germany have been allowed to possess up to 25 grams of dried cannabis and grow up to three marijuana plants. The next step, which came in July, was the introduction of so-called “cannabis social clubs,” where members can collectively grow and distribute marijuana, but the initiative has faced numerous legal and organizational challenges.
Details of the cannabis project in Hanover
Hanover, led by Green Party Mayor Belit Onay, is launching a five-year project that will allow 4,000 city residents to legally purchase cannabis. Participants will register online or at designated stores, receiving pseudonymous identification cards that will allow them to buy cannabis at three authorized points of sale.
The goal is to monitor the social, health and economic effects of legalized cannabis, while also reducing problems related to contamination and the increase in THC concentrations in black market products.
Led by the Medical School Hannover (MHH), the study will track participants’ behavior and health outcomes throughout the project.
Details of the project in Frankfurt
Similarly, Frankfurt am Main has launched its own research project under the supervision of Elke Voitl and Artur Schroers. Four stores will be opened to sell cannabis to adults, with a focus on consumer safety and health.
Sanity Group GmbH, experienced in regulated cannabis distribution in Switzerland, is responsible for implementing the project, which also aims to combat the black market by offering pure, tested products.
Expected results and next steps
Both cities have high expectations for their projects. Regulated sales systems are expected to potentially reduce crime related to illegal drug trafficking, reduce health risks associated with contaminated products and improve youth protection. Compliance with German age regulations and health checks are intended to ensure a safe environment for consumers and local communities.
Legalizing cannabis sales in these two cities has the potential to bring significant economic and social changes, both by generating new revenue for the cities and by changing public perceptions of cannabis.
Comparison with other international models
Similar initiatives have been implemented in various parts of the world, including Switzerland and some US states, where regulated cannabis sales benefit both consumers and local governments. The German projects could provide valuable data to help shape future drug policies both in Europe and around the world.
The pilot projects in Frankfurt and Hanover have the potential to become a milestone in the evolution of German and global cannabis policy. The data from these studies could define the future of drug regulation, paving the way for a safer and more regulated future for cannabis use.
__
(Featured image by Leonhard_Niederwimmer via Pixabay)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in FaktyKonopne. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us
-
Cannabis1 week ago
European Commission Launches Investigation into Italy’s CBD and Hemp Flower Ban
-
Fintech2 days ago
Azimut Relaunches Plan to Create a Fintech Bank, and Partners with Illimity
-
Impact Investing1 week ago
Greenhouse Gases in the Atmosphere Continue to Increase: New Record for CO2 at 420 ppm in 2023
-
Impact Investing2 weeks ago
FoodSeed Selects 7 Made in Italy Startups that Bring Innovation to the Agri-Food Supply Chain